Abstract
Vascular endothelial growth factor is the factor that causes increased capillary permeability and therefore the most serious manifestations of ovarian hyperstimulation syndrome. Dopamine agonists can both prevent and treat ovarian hyperstimulation syndrome by blocking expression of the vascular endothelial growth factor receptor.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Animals
-
Dopamine Agonists / therapeutic use*
-
Evidence-Based Medicine
-
Female
-
Fertility Agents, Female / adverse effects*
-
Humans
-
Ovarian Hyperstimulation Syndrome / chemically induced
-
Ovarian Hyperstimulation Syndrome / drug therapy*
-
Ovarian Hyperstimulation Syndrome / metabolism
-
Ovarian Hyperstimulation Syndrome / prevention & control*
-
Ovary / drug effects*
-
Ovary / metabolism
-
Ovulation / drug effects*
-
Ovulation Induction / adverse effects*
-
Practice Guidelines as Topic
-
Receptors, Vascular Endothelial Growth Factor / drug effects
-
Receptors, Vascular Endothelial Growth Factor / metabolism
-
Risk Assessment
-
Risk Factors
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Dopamine Agonists
-
Fertility Agents, Female
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Receptors, Vascular Endothelial Growth Factor